scholarly journals Manufacturing of the IFMIF HFTM double compartment prototype

2017 ◽  
Vol 124 ◽  
pp. 1068-1072 ◽  
Author(s):  
Florian Schwab ◽  
Frederik Arbeiter ◽  
Christine Klein ◽  
Georg Schlindwein
Keyword(s):  
2021 ◽  
pp. 135918352110288
Author(s):  
Eva Hemmungs Wirtén

This article is about an everyday paper object: an envelope. However, as opposed to most other flat paper containers, the enveloppe Soleau can only be bought from L’Institut national de la propriété industrielle (INPI) in Paris. At the cost of €15 you get a perforated, double-compartment envelope allowing you to constitute proof of creation and assign a precise date to your idea or project. But the enveloppe Soleau is something much more than just a simple and cheap way by which you can prove priority in any creative domain. It is a material footprint anchored to centuries of practices associated with disclosure and secrecy, a gateway into the infrastructure of the intellectual property system and its complicated relationship to the forms of knowledge it purports to hold. The purpose of this article is to consider the making of the enveloppe Soleau as a bureaucratic document, a material device performing a particular kind of legal paperwork. In four different vignettes, the article tracks the material becoming of the enveloppe Soleau as an evidentiary receptacle, beginning by going back to early modern practices of secrecy and priority, continuing with its consolidation in two patents (from 1910 and 1911) to the inventor Eugène Soleau (1852–1929), and ending up, in 2016, dematerialized in the e-Soleau. As a bureaucratic document, the enveloppe Soleau shows just how much work a mundane paper object can perform, navigating a particular materiality (a patented double envelope); formalized processes of proof (where perforations have legal significance); the practices of double archiving (in an institution and with the individual) and strict temporal limitations (a decade). Ultimately, the enveloppe Soleau travels between the material and immaterial, between private and public, between secrecy and disclosure, but also between what we perceive of as the outside and inside of the intellectual property system.


2007 ◽  
Vol 85 (1) ◽  
pp. 78-84 ◽  
Author(s):  
Masayoshi Minegishi ◽  
Tsuneo Itoh ◽  
Narumi Fukawa ◽  
Tamie Kitaura ◽  
Junko Miura ◽  
...  

2018 ◽  
Vol 808 ◽  
pp. 427-432 ◽  
Author(s):  
Y. Asensio ◽  
C.M. Fernandez-Marchante ◽  
J. Lobato ◽  
P. Cañizares ◽  
M.A. Rodrigo

PLoS ONE ◽  
2014 ◽  
Vol 9 (5) ◽  
pp. e96254 ◽  
Author(s):  
Denae Wagner ◽  
Sandra Newbury ◽  
Philip Kass ◽  
Kate Hurley

1983 ◽  
Vol &NA; (173) ◽  
pp. 191???199 ◽  
Author(s):  
M. P. MURRAY ◽  
D. R. GORE ◽  
W. H. LANEY ◽  
G. M. GARDNER ◽  
L. A. MOLLINGER

2006 ◽  
Vol 34 (06) ◽  
pp. 1037-1045 ◽  
Author(s):  
Ruining Liu ◽  
Dongming Xing ◽  
Hong Lu ◽  
Hao Wu ◽  
Lijun Du

In order to study the pharmacokinetics of puerarin and ginsenoside Rg1 of cerebral blood nutrition (CBN) and its relationship with pharmacodynamics of platelet aggregation induced by ADP in rat, the blood samples after injection were collected. The concentrations of puerarin and ginsenoside Rg1 in plasma were determined by RP-HPLC, and the platelet aggregations were observed simultaneously. The data showed that there was distinct statistic significance ( p < 0.01) for puerarin processing, which was a single compartment model with quick elimination rate ( t 1/2β = 18 min ) and MRT (26 min), while ginsenoside Rg1 processing was a double compartment model with rapid distribution rate ( t 1/2α = 8 min ), slow elimination rate ( t 1/2β = 11 hours ) and MRT (3.3 hours). Effects of anti-platelet aggregation were presented at 5–10 min, 45–90 min and 6–8 hours after injection separately, and the corresponding concentrations of puerarin were 25–21 μg/ml, 4.5–0.8 μg/ml and 0 μg/ml, ginsenoside Rg1 were 7.6–6.7 μg/ml, 1.2–0.6 μg/ml and 1.8–0.5 μg/ml. The two components presented a positive correlation between their concentrations and the effect of anti-platelet aggregation in 5–10 min after CBN injection (coefficient of correlation were 0.999 and 0.995). However, it was noted that the effect was still stronger even when concentrations of puerarin and ginsenoside Rg1 in plasma decreased. Therefore, puerarin and ginsenoside Rg1 not only had different pharmacokinetics, but also had a positive correlation with platelet aggregation, just in 5–10 min after CBN injection.


2004 ◽  
Vol 260 (1/2) ◽  
pp. 301-310 ◽  
Author(s):  
Irene M. Cardoso ◽  
Claire L. Boddington ◽  
Bert H. Janssen ◽  
Oene Oenema ◽  
Thomas W. Kuyper

Sign in / Sign up

Export Citation Format

Share Document